Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Clinton Kemp

Thoracic Surgery (Cardiothoracic Vascular Surgery) Norfolk, VA Medical Doctor

NPI 1366592297 CMS profile 487852

600 Gresham Dr Ste 8600, Ste 8600, Norfolk, VA 23507

Open in the dashboard

General payments

$366,746

552 records reported · program years 2019–2025

Research payments

$602

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$146,840 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Clinton Kemp of Norfolk, VA is reported in the CMS Open Payments database as having received $366,746 across 552 general payments and $602 in research payments paid to them. Separately, studies naming them as principal investigator received $146,840 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $186,561 248
2024 General $87,698 156
2023 General $31,960 40
2022 General $13,785 25
2021 General $11,063 21
2020 General $16,684 37
2020 Research $602 8
2019 General $18,996 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Clinton Kemp
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Clinton Kemp were reported at $186,561. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Clinton Kemp Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $18,996 $886 $178–$3,167 $163
2020 $16,684 $341 $108–$1,605 $114
2021 $11,063 $453 $125–$1,886 $132
2022 $13,785 $695 $180–$2,566 $149
2023 $31,960 $745 $205–$2,662 $160
2024 $87,698 $799 $214–$2,967 $164
2025 $186,561 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $275,901 404 payments
  2. Abbott Laboratories $50,404 57 payments
  3. Medtronic Vascular, Inc. $23,400 34 payments
  4. Paragonix Technologies, Inc. $7,092 4 payments
  5. Edwards Lifesciences Corporation $3,682 11 payments
  6. W. L. Gore & Associates, Inc. $3,315 19 payments
  7. Bolton Medical Inc $1,347 4 payments
  8. Ethicon US, LLC $720 6 payments
  9. Abiomed $418 5 payments
  10. JenaValve Technology, Inc. $280 2 payments
  11. Other $187 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $213,969 63 payments
  2. Consulting Fee $65,075 20 payments
  3. Travel and Lodging $58,400 168 payments
  4. Food and Beverage $17,145 296 payments
  5. Honoraria $7,000 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $4,875 2 payments
  7. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $264,455 376 payments
  2. CoreValve Evolut Transcatheter Valve Systems $23,149 32 payments
  3. NAVITOR $22,429 22 payments
  4. PORTICO $14,096 13 payments
  5. CoreValve Evolut Transcatheter Valve Systems $9,867 10 payments
  6. Shipper $7,092 4 payments
  7. Canister $7,092 4 payments
  8. Sherpacool $7,092 4 payments
  9. AMPLATZER AMULET $6,250 2 payments
  10. JETI ALL IN ONE NON-STERILE KIT $5,750 2 payments
  11. Other $12,532 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TransMedics, Inc. $602 8 payments

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$221,122

Medicare's payments for the services billed

Medicare patients

323

Average age 77

Services billed

734

113 women, 210 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 73%
Heart failure 65%
Arthritis 45%
Atrial fibrillation 43%
Diabetes 42%
Chronic kidney disease 41%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

560 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record